ACM
ARDS

AIGH Capital Management’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

AIGH Capital Management’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150,591
Closed -$554K – 67
2021
Q3 		$554K Sell
150,591
-308,670
-67% -$1.43M 0.12% 50
2021
Q2 		$3.33M Buy
459,261
+35,904
+8% +$224K 0.6% 33
2021
Q1 		$2.5M Buy
423,357
+76,341
+22% +$516K 0.52% 39
2020
Q4 		$2.11M Buy
+347,016
New +$2.42M 0.86% 29

Other funds holding ARDS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AIGH Capital Management's ARDS Position: Q4 2021 in Review

AIGH Capital Management sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q4 2021, closing a stake of 150,591 shares — an estimated $554K sold.

AIGH Capital Management first reported a position in ARDS in Q4 2020 and held it in 4 quarters. The position peaked at $3.33M in Q2 2021. 20 funds tracked by Wall St. Rank hold ARDS as of Q4 2021.

  • AIGH Capital Management reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • AIGH Capital Management sold 150,591 Aridis Pharmaceuticals Inc. Common Stock shares in Q4 2021, an estimated $554K.
  • AIGH Capital Management first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • AIGH Capital Management's Aridis Pharmaceuticals Inc. Common Stock position peaked at $3.33M in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q4 2021.

Based on AIGH Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.